Physical Activity — Physical Activity and Dietary Behaviors of Adults 18 to 80 Years of Age
Citation(s)
AbuSabha R, Achterberg C Review of self-efficacy and locus of control for nutrition- and health-related behavior. J Am Diet Assoc. 1997 Oct;97(10):1122-32. Review.
Ammerman AS, Lindquist CH, Lohr KN, Hersey J The efficacy of behavioral interventions to modify dietary fat and fruit and vegetable intake: a review of the evidence. Prev Med. 2002 Jul;35(1):25-41.
Appendix B22 Dietary Quality: The Food Habits Questionnaire. In: St. Jeor ST, ed. Obesity Assessment: Tools, Methods, Interpretations. New York: Chapman & Hall, 1997, 806-812.
Armitage CJ, Conner M Efficacy of a minimal intervention to reduce fat intake. Soc Sci Med. 2001 May;52(10):1517-24.
Bauman AE Updating the evidence that physical activity is good for health: an epidemiological review 2000-2003. J Sci Med Sport. 2004 Apr;7(1 Suppl):6-19. Review.
Cook RF, Billings DW, Hersch RK, Back AS, Hendrickson A A field test of a web-based workplace health promotion program to improve dietary practices, reduce stress, and increase physical activity: randomized controlled trial. J Med Internet Res. 2007 Jun 19;9(2):e17.
Institutes of Medicine Dietary reference intakes: Energy, carbohydrates, fiber, fat, fatty acides, cholesterol, protein and amino acids. National Academy Press, 2002.
Kroeze W, Werkman A, Brug J A systematic review of randomized trials on the effectiveness of computer-tailored education on physical activity and dietary behaviors. Ann Behav Med. 2006 Jun;31(3):205-23. Review.
Kuller LH Dietary fat and chronic diseases: epidemiologic overview. J Am Diet Assoc. 1997 Jul;97(7 Suppl):S9-15. Review.
Sherwood NE, Jeffery RW The behavioral determinants of exercise: implications for physical activity interventions. Annu Rev Nutr. 2000;20:21-44. Review.
Silverstein LJ, Scott BJ, Zahrt H Dietary Quality: The Food Habits Questionnaire. In: St. Jeor ST, ed. Obesity Assessment: Tools, Methods, Interpretations. New York: Chapman & Hall; 1997: 281-291.
Spittaels H, De Bourdeaudhuij I, Vandelanotte C Evaluation of a website-delivered computer-tailored intervention for increasing physical activity in the general population. Prev Med. 2007 Mar;44(3):209-17. Epub 2007 Jan 2.
Tate DF, Jackvony EH, Wing RR A randomized trial comparing human e-mail counseling, computer-automated tailored counseling, and no counseling in an Internet weight loss program. Arch Intern Med. 2006 Aug 14-28;166(15):1620-5.
U S. Department of Health and Human Services and U.S. Department of Agriculture. Dietary Guidelines for Americans, 2005, 6th Edition. Washington D.C.: U.S. Government Printing Office, January, 2005.
U S. Department of Health and Human Services. Healthy People 2010: National health promotion and disease prevention objectives. Washington DC: U.S Department of Health and Human Services 2000.
U S. Dept of Health and Human Services: Physical Actvity and Health: A report of the Sugeon General. Atlanta GA: Centers for Disease Control and Prevention, National Center for Chronic Deases Prevention and Health Promotion 1996.
Wannamethee SG, Shaper AG Physical activity in the prevention of cardiovascular disease: an epidemiological perspective. Sports Med. 2001 Feb;31(2):101-14. Review.
Physical Activity and Dietary Behaviors of Adults 18 to 80 Years of Age
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
